BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37566671)

  • 1. Ischemic Cerebellar Stroke in a Young Patient With Neurofibromatosis Type 2: A Case Report.
    Trautman A; Sandhu D
    S D Med; 2023 Apr; 76(4):163-166. PubMed ID: 37566671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
    Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
    J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal neurofibrosarcoma in a patient with neurofibromatosis. 2: A case report and review of the literature.
    Chen Y; Diamond AS; Vaheesan KR; Schneider S; Valderrama E
    Pediatr Pathol Mol Med; 2003; 22(5):375-81. PubMed ID: 14692188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
    Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
    Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.
    Alanin MC; Klausen C; Caye-Thomasen P; Thomsen C; Fugleholm K; Poulsgaard L; Lassen U; Mau-Sorensen M; Hofland KF
    Int J Neurosci; 2016 Nov; 126(11):1002-6. PubMed ID: 26365467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
    Cumpston EC; Rhodes SD; Yates CW
    Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal amyotrophy in neurofibromatosis 2.
    Trivedi R; Byrne J; Huson SM; Donaghy M
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):257-61. PubMed ID: 10896706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 2 initially presenting as a preauricular mass: a case report.
    Lan WC; Aoh Y; Chen RY; Tien HC; Lin CD
    J Otolaryngol Head Neck Surg; 2020 Jun; 49(1):45. PubMed ID: 32591014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults.
    Gugel I; Mautner VF; Kluwe L; Tatagiba MS; Schuhmann MU
    Front Neurol; 2018; 9():733. PubMed ID: 30250447
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke in a child with neurofibromatosis type 2.
    Ng J; Mordekar SR; Connolly DJ; Baxter P
    Eur J Paediatr Neurol; 2009 Jan; 13(1):77-9. PubMed ID: 18406647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis 2 in the pediatric age group.
    Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
    Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.